Every year, the American Cancer Society issues its Facts and Figures Report detailing cancer’s estimated trends and statistics for the year. Below is an overview of the organization’s projections for prostate cancer this year:
- An estimated 233,000 new cases of prostate cancer will occur in 2014, meaning that prostate cancer continues to be the most frequently diagnosed cancer in men aside from skin cancer and is the second-leading cause of cancer related death in men in the U.S.
- About 1 man in 36 will die of prostate cancer.
- Prostate cancer occurs mainly in older men. About 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66.
- Treatment options for prostate cancer vary depending on age, the stage of the disease and the grade of the tumor, among other factors. Current treatment options include surgery, stereotactic body radiation therapy and brachytherapy.
CyberKnife Center of Chicago treats prostate cancer with stereotactic body radiation therapy (SBRT), a powerful, noninvasive treatment approach that targets radiation beams to match the size and shape of a patients’ tumor, minimizing damage to surrounding tissue.
Our center uses CyberKnife® technology to deliver SBRT. If you or a loved one is facing a prostate cancer diagnosis, click here for additional information about prostate cancer and our treatment method. To read the full 2014 Facts and Figures Report from the American Cancer Society, click here.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.